SGTTX
Price
$145.86
Change
-$3.06 (-2.05%)
Updated
Sep 14 closing price
Net Assets
4.75B
SLMCX
Price
$239.92
Change
-$5.04 (-2.06%)
Updated
Sep 14 closing price
Net Assets
29.52B
Interact to see
Advertisement

SGTTX vs SLMCX

SGTTX vs SLMCX Comparison Chart in %
View a ticker or compare two or three
VS
SGTTX vs. SLMCX commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGTTX is a Buy and SLMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 29.5B vs. SGTTX (4.75B). SGTTX (0.00) and SLMCX (0.00) have matching dividends . SGTTX was incepted earlier than SLMCX: SGTTX (17 years) vs SLMCX (43 years). SLMCX (1.16) is less costly to investors than SGTTX (0.98). SLMCX is a more actively managed with annual turnover of: 47.00 vs. SGTTX (25.00). SGTTX has a lower initial minimum investment than SLMCX: SGTTX (0) vs SLMCX (2000). SLMCX (56.14) and SGTTX (55.62) have marching annual gain over last year. SGTTX return over 5 years is better than : 91.24 vs. SLMCX (83.85).
SGTTXSLMCXSGTTX / SLMCX
Total Expense Ratio0.951.1682%
Annual Report Gross Expense Ratio0.981.1684%
Fund Existence17 years43 years-
Gain YTD51.63753.10897%
Front LoadN/A6%-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.75B29.5B16%
Annual Yield % from dividends0.000.00-
Returns for 1 year55.6256.1499%
Returns for 3 years126.95129.8798%
Returns for 5 years91.2483.85109%
Returns for 10 years339.00293.44116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AARD5.550.42
+8.19%
Aardvark Therapeutics Inc
AFRM73.381.94
+2.72%
Affirm Holdings
DYN18.520.31
+1.70%
Dyne Therapeutics
POM0.71N/A
-0.15%
Pomdoctor Limited
INDI3.13-0.22
-6.57%
indie Semiconductor